Kenya-tested malaria vaccine gets WHO approval

malaria treatment

A Kenyan health worker measures the dosage of a malaria vaccine in Ndhiwa, Homabay County on September 13, 2019. PHOTO | BRIAN ONGORO | AFP

A malaria jab that was tested in Kenya alongside other countries, has been prequalified for use by the World Health Organisation (WHO).

It is expected to cost Ksh300 to Ksh600 ($1.9 to $3.8), becoming the world’s second vaccine to be added to the global prequalified list.